Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Gastrointestinal Cancer
Published in: Journal of Gastrointestinal Cancer 3/2022

14-08-2021 | Hamartoma | Case Report

Intrahepatic Bile Duct Adenoma Masquerading as Metastatic Carcinoma in a Case of Gastric Carcinoma: a Diagnostic Dilemma

Authors: Pallavi Saraf, Jyotsna Naresh Bharti, Jeewan Ram Vishnoi

Published in: Journal of Gastrointestinal Cancer | Issue 3/2022

Login to get access

Excerpt

Intrahepatic bile duct adenoma is a rare benign tumor originating from bile duct epithelium and accounts for 1.3% of primary liver tumors [1]. It is thought to be a proliferative lesion of the bile duct that occurs after injury or inflammation [2]. Few consider it a peribiliary gland hamartoma due to sharing common antigens between BDA and peribiliary glands, suggesting a common line of differentiation [3]. In contrast, gastric carcinoma is a common malignancy and stands seventh worldwide among malignancies [4, 5]. …
Literature
1.
Allaire GS, Rabin L, Ishak KG, Sesterhenn IA. Bile duct adenoma. A study of 152 cases. Am J Surg Pathol. 1988 Sep;12(9):708–15.
2.
Jlang C, Che J. A case of intrahepatic bile duct adenoma. J Diagn Pathol. 1998;5(2):117.
3.
Wu WW, Gu M, Lu D. Cytopathologic, histopathologic, and immunohistochemical features of intrahepatic clear cell bile duct adenoma: a case report and review of the literature. Case Rep Pathol. 2014;2014:874826.
4.
Nashimoto A, Akazawa K, Isobe Y, Miyashiro I, Katai H, Kodera Y, Tsujitani S, Seto Y, Furukawa H, Oda I, Ono H. Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry. Gastric Cancer. 2013;16(1):1–27.CrossRef
5.
Fidler MM, Gupta S, Soerjomataram I, Ferlay J, Steliarova-Foucher E, Bray F. Cancer incidence and mortality among young adults aged 20–39 years worldwide in 2012: a population-based study. The Lancet Oncology. 2017;18(12):1579–89.CrossRef
6.
Namikawa T, Tsuda S, Fujisawa K, Munekage E, Iwabu J, Munekage M, Uemura S, Tsujii S, Maeda H, Kitagawa H, Iguchi M, Murakami I, Kobayashi M, Hanazaki K. Intrahepatic bile duct adenoma in a patient with gastric cancer. Int Cancer Conf J. 2018;8(1):7–11.CrossRef
7.
Chen L, Xu MY, Chen F. Bile duct adenoma: a case report and literature review. World J Surg Oncol. 2014;12(1):1–7.CrossRef
8.
Koga F, Tanaka H, Takamatsu S, Baba S, Takihara H, Hasegawa A, Yanagihara E, Inoue T, Nakano T, Ueda C, Ono W. A case of very large intrahepatic bile duct adenoma followed for 7 years. World J Clin Oncol. 2012;3(4):63.CrossRef
9.
Chuy JA, Garg I, Graham RP, VanBuren WM, Venkatesh SK. Imaging features of bile duct adenoma: case series and review of literature. Diagnostic and Interventional Radiology. 2018;24(5):249.CrossRef
10.
Hasebe T, Mukai K, Sakamoto M, Hirohashi S, Kawano N, Konishi M, Ryu M, Fukamachi S. Cholangiocarcinoma arising in bile duct adenoma with focal area of bile duct hamartoma. Virchows Archiv. 1995;426(2):209–13.CrossRef
Metadata
Title
Intrahepatic Bile Duct Adenoma Masquerading as Metastatic Carcinoma in a Case of Gastric Carcinoma: a Diagnostic Dilemma
Authors
Pallavi Saraf
Jyotsna Naresh Bharti
Jeewan Ram Vishnoi
Publication date
14-08-2021
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 3/2022
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-021-00681-3

Other articles of this Issue 3/2022

Journal of Gastrointestinal Cancer 3/2022 Go to the issue

Original Research

Pancreaticoduodenectomy: Impact of Volume on Outcomes at a Tertiary Care Center—Our Experience in Single Institute of Nepal

Original Research

Microbial Azurin Immobilized on Nano-Chitosan as Anticancer and Antibacterial Agent Against Gastrointestinal Cancers and Related Bacteria

Case Report

Significant Response to Camrelizumab Plus Targeted Drugs in Recurrent Intrahepatic Cholangiocarcinoma: a Case Report and Literature Review

Original Research

The Autophagy-Inducing Mechanisms of Vitexin, Cinobufacini, and Physalis alkekengi Hydroalcoholic Extract against Breast Cancer in vitro and in vivo

Original Research

Hypermethylation of MIR129-2 Regulates SOX4 Transcription and Associates with Metastasis in Patients with Colorectal Cancer

Original Research

The Use of Single-Agent Versus Multiple-Agent Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Rectal Cancer
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits